† Maximum benefit is $20 off, on up to 5 prescriptions, depending
on your out-of-pocket costs. Not valid for patients participating in Medicare, Medicaid,
government (public insurance) programs, or any private payor in the state of Massachusetts
and where prohibited by law.
‡ See terms and conditions on offer material.
AMBIEN CR is indicated to help you fall asleep and/or stay asleep.
AMBIEN is indicated for short-term treatment to help you fall asleep.
IMPORTANT SAFETY INFORMATION
AMBIEN and AMBIEN CR are treatment options you and your doctor can consider along
with lifestyle changes. When taking either of them, don’t drive or operate machinery.
Plan to devote 7 to 8 hours to sleep before being active. Sleepwalking, and eating
or driving while not fully awake, with memory loss for the event, as well as abnormal
behaviors such as being more outgoing or aggressive than normal, confusion, agitation,
and hallucinations may occur. Don’t take it with alcohol as it may increase these
behaviors. In patients with depression, worsening of depression, including risk
of suicide may occur. If you experience any of these behaviors contact your doctor
immediately. Allergic reactions such as shortness of breath, swelling of your tongue or throat,
may occur and in rare cases may be fatal. If you have an allergic reaction while
using AMBIEN or AMBIEN CR, contact your doctor immediately. Side effects of AMBIEN
CR may include next-day drowsiness, dizziness and headache. There is a low occurrence
of side effects associated with the short-term use of AMBIEN. The most commonly
observed side effects in controlled clinical trials were drowsiness, dizziness,
and diarrhea. AMBIEN is taken for 7 to 10 days –or longer as advised by your provider.
AMBIEN CR can be taken as long as your doctor recommends. AMBIEN and AMBIEN CR have
some risk of dependency. They are non-narcotic.
Please refer to the AMBIEN CR full prescribing information and medication guide.
Please refer to the AMBIEN full prescribing information and medication guide.
Click here for information on drug anti-counterfeiting.